For the week of June 22, TheStreet highlights Yahoo! Inc's (YHOO) shareholder meeting, along with the key earnings reports and economic data Wall Street will be watching. Yahoo!, the second most-used search engine in the U.S., is scheduled to meet in Santa Clara, Calif. as the board's current nine directors are up for re-election. Investors will also be asked to cast a nonbinding, advisory vote on executive compensation. Yahoo! is a global technology company, delivering digital content and experiences, across devices and globally. The notable companies releasing their latest quarterly financial results include the casual restaurant chain Sonic Corp (SONC), cruise vacation company Carnival Corp (CCL), Darden Restaurants Inc (DRI), mobile communications and services provider BlackBerry Ltd (BBRY), agricultural products provider Monsanto Co (MON), home furnishings retailer Bed Bath & Beyond Inc (BBBY), Nike (NKE), Accenture Plc (ACN), Micron Technology Inc (MU), and athletic shoe retailer Finish Line Inc (FINL). On the economic calendar, we point out four key data. This week, Wall Street awaits existing home sales, durable goods orders, new home sales, and consumer sentiment. Existing home sales tally provides a gauge of not only the demand for housing, but the economic momentum. Durable goods orders reflect the new orders placed with domestic manufacturers for immediate and future delivery of factory hard goods. New home sales measure the number of newly constructed homes with a committed sale during the month. Consumer sentiment is directly related to the strength of consumer spending, which accounts for more than two-thirds of the economy. The consumer sentiment level is determined by the University of Michigan's Consumer Survey Center which questions 500 households each month on their financial conditions and attitudes about the economy. TheStreet's Kurumi Fukushima reports in New York.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.